ClinConnect ClinConnect Logo
Search / Trial NCT05165654

Improving Hallucinations by Targeting the RSTS with TES

Launched by BETH ISRAEL DEACONESS MEDICAL CENTER · Dec 14, 2021

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Transcranial Electrical Stimulation Electroencephalography

ClinConnect Summary

This clinical trial is studying a new way to help people who experience hallucinations, particularly those who hear voices or see things that aren't there. Researchers believe that a specific area in the brain called the right superior temporal sulcus (rSTS) plays a key role in these hallucinations. They want to see if a type of non-invasive brain stimulation can improve brain function in this area, which may help reduce the frequency and severity of hallucinations.

To participate in this study, you need to be between 18 and 50 years old, speak English well, and currently be experiencing hallucinations. It's important that you haven’t recently undergone other similar treatments. If you join the study, you will receive the brain stimulation therapy, and researchers will monitor your progress. They are looking for individuals of all genders who are actively dealing with these challenges, so this trial could be an opportunity to explore a new treatment option that might make a difference in your daily life.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Aged 18-50 years of age
  • 2. Proficient in English
  • 3. Able to give informed consent
  • 4. Actively experiencing hallucinations (tactile, auditory, visual, etc.)
  • 5. Has not recently participated in tES/TMS treatments
  • Exclusion Criteria:
  • 1. Substance abuse or dependence (w/in past 6 months)
  • 2. Those who are pregnant/breastfeeding
  • 3. History of head injury with \> 15 minutes of loss of consciousness/mal sequelae
  • 4. DSM-V intellectual disability
  • 5. Having a non-removable ferromagnetic metal within the body (particularly in the head)
  • 6. History of seizures

About Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center (BIDMC) is a leading academic medical center located in Boston, Massachusetts, affiliated with Harvard Medical School. Renowned for its commitment to cutting-edge research and innovation in healthcare, BIDMC fosters a collaborative environment that integrates patient care, education, and scientific investigation. The center actively sponsors clinical trials across a variety of disciplines, aiming to advance medical knowledge and improve patient outcomes. With a focus on translational medicine, BIDMC's research initiatives engage multidisciplinary teams to address complex health challenges and translate findings into effective therapeutic strategies.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Paulo Lizano, MD, PhD

Principal Investigator

Beth Israel Deaconess Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials